Loading company…
Symbio provides clinical research services, including trials from Phase 1 to Phase 4.
Founded in 2002 and based in New York, Symbio is a clinical research organization specializing in dermatology. It supports proof-of-concept work, medical device studies, and Phase 1 to Phase 4 trials, with services including project and data management, monitoring, biostatistics, and recruitment. In November 2023, ARCHIMED combined Symbio and Proinnovera to form Symbio Proinnovera. Its subsidiary Dow Development Laboratories provides drug product design, development, and topical formulation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in